Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of TAK-491 in Essential Hypertension
NCT00362115Phase 2Completed
- Sponsor
- Takeda
- Start
- May 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started May 2006; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00362115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362115.